{"entity":{"type":"insider","cik":"0001308428","url":"/insider/0001308428","json_url":"/insider/0001308428.json","name":"GALLAHUE KIERAN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":65,"n_filings":51,"first":"2004-11-12","last":"2024-02-26","span_basis":"filed_date"},"name_variants":[{"name":"GALLAHUE KIERAN","source":"filing","n_filings":5,"first_seen":"2016-05-17","last_seen":"2024-02-26"},{"name":"Gallahue Kieran","source":"filing","n_filings":46,"first_seen":"2004-11-12","last_seen":"2014-05-20"}],"transactions":[{"id":2889954,"accession":"0001225208-24-002963","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-24-002963","line_url":"/filing/0001225208-24-002963#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001308428","owner_name":"GALLAHUE KIERAN","owner_display_name":"GALLAHUE KIERAN","owner_url":"/insider/0001308428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3058.0,"shares_display":"3,058","price_per_share":87.61,"price_display":"87.61","price_state":"stated","total_value":267911.38,"total_display":"267,911.38","total_whole":"267,911","shares_owned_after":67219.0,"shares_owned_after_display":"67,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-23","filed_date":"2024-02-26","scope":"insider"},{"id":6832779,"accession":"0001225208-22-001657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-22-001657","line_url":"/filing/0001225208-22-001657#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001308428","owner_name":"GALLAHUE KIERAN","owner_display_name":"GALLAHUE KIERAN","owner_url":"/insider/0001308428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32256.0,"shares_display":"32,256","price_per_share":110.7859,"price_display":"110.79","price_state":"stated","total_value":3573509.9904,"total_display":"3,573,509.99","total_whole":"3,573,510","shares_owned_after":3433.0,"shares_owned_after_display":"3,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-08","scope":"insider"},{"id":4169136,"accession":"0001225208-17-002461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-17-002461","line_url":"/filing/0001225208-17-002461#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001308428","owner_name":"GALLAHUE KIERAN","owner_display_name":"GALLAHUE KIERAN","owner_url":"/insider/0001308428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":90.1,"price_display":"90.10","price_state":"stated","total_value":270300.0,"total_display":"270,300.00","total_whole":"270,300","shares_owned_after":9042.0,"shares_owned_after_display":"9,042","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-06","scope":"insider"},{"id":3187775,"accession":"0001225208-16-042548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-16-042548","line_url":"/filing/0001225208-16-042548#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001308428","owner_name":"GALLAHUE KIERAN","owner_display_name":"GALLAHUE KIERAN","owner_url":"/insider/0001308428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":84.6334,"price_display":"84.63","price_state":"stated","total_value":253900.2,"total_display":"253,900.20","total_whole":"253,900","shares_owned_after":6042.0,"shares_owned_after_display":"6,042","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-12-01","scope":"insider"},{"id":2856457,"accession":"0001562180-16-002368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002368","line_url":"/filing/0001562180-16-002368#line-1","is_derivative":false,"issuer_cik":"0001271214","issuer_name":"Intersect ENT, Inc.","issuer_ticker":"XENT","issuer_name_source":null,"issuer_url":"/issuer/0001271214","owner_cik":"0001308428","owner_name":"GALLAHUE KIERAN","owner_display_name":"GALLAHUE KIERAN","owner_url":"/insider/0001308428","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":12.6389,"price_display":"12.64","price_state":"stated","total_value":101111.2,"total_display":"101,111.20","total_whole":"101,111","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-17","scope":"insider"},{"id":6380737,"accession":"0001225738-14-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225738-14-000019","line_url":"/filing/0001225738-14-000019#line-2","is_derivative":false,"issuer_cik":"0001308428","issuer_name":"CAREFUSION Corp","issuer_ticker":"CFN","issuer_name_source":null,"issuer_url":"/issuer/0001308428","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":42.98,"price_display":"42.98","price_state":"stated","total_value":4298000.0,"total_display":"4,298,000.00","total_whole":"4,298,000","shares_owned_after":305122.0,"shares_owned_after_display":"305,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-20","filed_date":"2014-05-20","scope":"insider"},{"id":7037684,"accession":"0001225738-14-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225738-14-000002","line_url":"/filing/0001225738-14-000002#line-1","is_derivative":false,"issuer_cik":"0001308428","issuer_name":"CAREFUSION Corp","issuer_ticker":"CFN","issuer_name_source":null,"issuer_url":"/issuer/0001308428","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":41.05,"price_display":"41.05","price_state":"stated","total_value":1026250.0,"total_display":"1,026,250.00","total_whole":"1,026,250","shares_owned_after":122873.0,"shares_owned_after_display":"122,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-09","filed_date":"2014-01-10","scope":"insider"},{"id":4688620,"accession":"0001225738-13-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225738-13-000044","line_url":"/filing/0001225738-13-000044#line-2","is_derivative":false,"issuer_cik":"0001308428","issuer_name":"CAREFUSION Corp","issuer_ticker":"CFN","issuer_name_source":null,"issuer_url":"/issuer/0001308428","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22883.0,"shares_display":"22,883","price_per_share":40.1,"price_display":"40.10","price_state":"stated","total_value":917608.3,"total_display":"917,608.30","total_whole":"917,608","shares_owned_after":147873.0,"shares_owned_after_display":"147,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-02","scope":"insider"},{"id":4688615,"accession":"0001225738-13-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225738-13-000044","line_url":"/filing/0001225738-13-000044#line-1","is_derivative":false,"issuer_cik":"0001308428","issuer_name":"CAREFUSION Corp","issuer_ticker":"CFN","issuer_name_source":null,"issuer_url":"/issuer/0001308428","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2117.0,"shares_display":"2,117","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":84680.0,"total_display":"84,680.00","total_whole":"84,680","shares_owned_after":170756.0,"shares_owned_after_display":"170,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-29","filed_date":"2013-12-02","scope":"insider"},{"id":8883390,"accession":"0001140361-11-001880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-11-001880","line_url":"/filing/0001140361-11-001880#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32590.0,"shares_display":"32,590","price_per_share":35.06,"price_display":"35.06","price_state":"stated","total_value":1142605.4,"total_display":"1,142,605.40","total_whole":"1,142,605","shares_owned_after":56921.794,"shares_owned_after_display":"56,921.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-05","filed_date":"2011-01-07","scope":"insider"},{"id":7561031,"accession":"0001140361-10-050884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-050884","line_url":"/filing/0001140361-10-050884#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":700000.0,"total_display":"700,000.00","total_whole":"700,000","shares_owned_after":56921.794,"shares_owned_after_display":"56,921.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-17","filed_date":"2010-12-21","scope":"insider"},{"id":7503983,"accession":"0001140361-10-048891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-048891","line_url":"/filing/0001140361-10-048891#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":33.1492,"price_display":"33.15","price_state":"stated","total_value":994476.0,"total_display":"994,476.00","total_whole":"994,476","shares_owned_after":56921.794,"shares_owned_after_display":"56,921.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-06","filed_date":"2010-12-08","scope":"insider"},{"id":7503836,"accession":"0001140361-10-045138","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-10-045138","line_url":"/filing/0001140361-10-045138","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":33.11966666666667,"price_display":"33.12","price_state":"stated","total_value":794872.0,"total_display":"794,872.00","total_whole":"794,872","shares_owned_after":63589.794,"shares_owned_after_display":"63,589.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-10","filed_date":"2010-11-12","scope":"insider","n_lines":2},{"id":7757159,"accession":"0001140361-10-036768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-036768","line_url":"/filing/0001140361-10-036768#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":32.383,"price_display":"32.38","price_state":"stated","total_value":647660.0,"total_display":"647,660.00","total_whole":"647,660","shares_owned_after":63589.794,"shares_owned_after_display":"63,589.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-07","filed_date":"2010-09-09","scope":"insider"},{"id":7707193,"accession":"0001140361-10-035719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-035719","line_url":"/filing/0001140361-10-035719#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.708,"price_display":"60.71","price_state":"stated","total_value":1214160.0,"total_display":"1,214,160.00","total_whole":"1,214,160","shares_owned_after":31794.897,"shares_owned_after_display":"31,794.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-27","filed_date":"2010-08-31","scope":"insider"},{"id":7432832,"accession":"0001140361-10-032103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-032103","line_url":"/filing/0001140361-10-032103#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":67.599,"price_display":"67.60","price_state":"stated","total_value":675990.0,"total_display":"675,990.00","total_whole":"675,990","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-06","scope":"insider"},{"id":7299219,"accession":"0001140361-10-029133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-029133","line_url":"/filing/0001140361-10-029133#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-09","filed_date":"2010-07-12","scope":"insider"},{"id":7503556,"accession":"0001140361-10-028774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-028774","line_url":"/filing/0001140361-10-028774#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":61.94,"price_display":"61.94","price_state":"stated","total_value":309700.0,"total_display":"309,700.00","total_whole":"309,700","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-06","filed_date":"2010-07-07","scope":"insider"},{"id":7403492,"accession":"0001140361-10-025902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-025902","line_url":"/filing/0001140361-10-025902#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","total_whole":"325,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-14","filed_date":"2010-06-17","scope":"insider"},{"id":7756761,"accession":"0001140361-10-024924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-024924","line_url":"/filing/0001140361-10-024924#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":64.32,"price_display":"64.32","price_state":"stated","total_value":321600.0,"total_display":"321,600.00","total_whole":"321,600","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-07","filed_date":"2010-06-09","scope":"insider"},{"id":7687734,"accession":"0001140361-10-021828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-021828","line_url":"/filing/0001140361-10-021828#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":69.1836,"price_display":"69.18","price_state":"stated","total_value":691836.0,"total_display":"691,836.00","total_whole":"691,836","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-13","filed_date":"2010-05-17","scope":"insider"},{"id":7503453,"accession":"0001140361-10-019431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-019431","line_url":"/filing/0001140361-10-019431#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17600.0,"shares_display":"17,600","price_per_share":67.1532,"price_display":"67.15","price_state":"stated","total_value":1181896.32,"total_display":"1,181,896.32","total_whole":"1,181,896","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-05","filed_date":"2010-05-06","scope":"insider"},{"id":7563789,"accession":"0001140361-10-015562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-015562","line_url":"/filing/0001140361-10-015562#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":63.632,"price_display":"63.63","price_state":"stated","total_value":1590800.0,"total_display":"1,590,800.00","total_whole":"1,590,800","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-05","filed_date":"2010-04-06","scope":"insider"},{"id":7582320,"accession":"0001140361-10-011333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-011333","line_url":"/filing/0001140361-10-011333#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","total_whole":"600,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-10","filed_date":"2010-03-11","scope":"insider"},{"id":7178013,"accession":"0001140361-10-010785","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-10-010785","line_url":"/filing/0001140361-10-010785","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":58.818666666666665,"price_display":"58.82","price_state":"stated","total_value":882280.0,"total_display":"882,280.00","total_whole":"882,280","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-05","filed_date":"2010-03-09","scope":"insider","n_lines":2},{"id":7582180,"accession":"0001140361-10-007526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-10-007526","line_url":"/filing/0001140361-10-007526","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":55.60168,"price_display":"55.60","price_state":"stated","total_value":1668050.4,"total_display":"1,668,050.40","total_whole":"1,668,050","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-17","filed_date":"2010-02-19","scope":"insider","n_lines":2},{"id":7706044,"accession":"0001140361-10-005749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-10-005749","line_url":"/filing/0001140361-10-005749#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":54.347,"price_display":"54.35","price_state":"stated","total_value":1086940.0,"total_display":"1,086,940.00","total_whole":"1,086,940","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-09","filed_date":"2010-02-11","scope":"insider"},{"id":6086848,"accession":"0001140361-09-028890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-028890","line_url":"/filing/0001140361-09-028890#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":52.04,"price_display":"52.04","price_state":"stated","total_value":260200.0,"total_display":"260,200.00","total_whole":"260,200","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-10","filed_date":"2009-12-11","scope":"insider"},{"id":5716606,"accession":"0001140361-09-027237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-027237","line_url":"/filing/0001140361-09-027237#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17400.0,"shares_display":"17,400","price_per_share":50.45,"price_display":"50.45","price_state":"stated","total_value":877830.0,"total_display":"877,830.00","total_whole":"877,830","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-19","filed_date":"2009-11-23","scope":"insider"},{"id":5699227,"accession":"0001140361-09-026623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-026623","line_url":"/filing/0001140361-09-026623#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-13","filed_date":"2009-11-17","scope":"insider"},{"id":5588319,"accession":"0001140361-09-025642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-025642","line_url":"/filing/0001140361-09-025642#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":48.916,"price_display":"48.92","price_state":"stated","total_value":366870.0,"total_display":"366,870.00","total_whole":"366,870","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-10","filed_date":"2009-11-12","scope":"insider"},{"id":5601683,"accession":"0001140361-09-023944","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-09-023944","line_url":"/filing/0001140361-09-023944#line-4","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":87500.0,"total_display":"87,500.00","total_whole":"87,500","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-26","filed_date":"2009-10-27","scope":"insider"},{"id":5601681,"accession":"0001140361-09-023944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-023944","line_url":"/filing/0001140361-09-023944#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250.0,"shares_display":"3,250","price_per_share":50.01,"price_display":"50.01","price_state":"stated","total_value":162532.5,"total_display":"162,532.50","total_whole":"162,533","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-23","filed_date":"2009-10-27","scope":"insider"},{"id":5816424,"accession":"0001140361-09-023215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-023215","line_url":"/filing/0001140361-09-023215#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":46.634,"price_display":"46.63","price_state":"stated","total_value":349755.0,"total_display":"349,755.00","total_whole":"349,755","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-12","filed_date":"2009-10-13","scope":"insider"},{"id":6015990,"accession":"0001140361-09-020768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-020768","line_url":"/filing/0001140361-09-020768#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":46.0178,"price_display":"46.02","price_state":"stated","total_value":345133.5,"total_display":"345,133.50","total_whole":"345,134","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-10","filed_date":"2009-09-11","scope":"insider"},{"id":9230901,"accession":"0001140361-09-018793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-018793","line_url":"/filing/0001140361-09-018793","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":45.163252,"price_display":"45.16","price_state":"stated","total_value":338724.39,"total_display":"338,724.39","total_whole":"338,724","shares_owned_after":8423.897,"shares_owned_after_display":"8,423.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-10","filed_date":"2009-08-12","scope":"insider","n_lines":5},{"id":6085799,"accession":"0001140361-09-018731","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-09-018731","line_url":"/filing/0001140361-09-018731","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":45.163252,"price_display":"45.16","price_state":"stated","total_value":338724.39,"total_display":"338,724.39","total_whole":"338,724","shares_owned_after":8223.897,"shares_owned_after_display":"8,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-10","filed_date":"2009-08-12","scope":"insider","n_lines":5},{"id":5588201,"accession":"0001140361-09-016398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-016398","line_url":"/filing/0001140361-09-016398#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-10","filed_date":"2009-07-14","scope":"insider"},{"id":5904010,"accession":"0001140361-09-014891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-014891","line_url":"/filing/0001140361-09-014891#line-2","is_derivative":false,"issuer_cik":"0000943819","issuer_name":"RESMED INC","issuer_ticker":"RMD","issuer_name_source":null,"issuer_url":"/issuer/0000943819","owner_cik":"0001308428","owner_name":"Gallahue Kieran","owner_display_name":"Gallahue Kieran","owner_url":"/insider/0001308428","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"ResMed Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":3223.897,"shares_owned_after_display":"3,223.90","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-12","filed_date":"2009-06-17","scope":"insider"}],"collapsed":true,"next_cursor":"2009-06-12|5904010","ledger_fault":false,"count":{"value":65,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":62,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":65},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Director","n_filings":4,"first_seen":"2016-12-01","last_seen":"2024-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001271214","name":"Intersect ENT, Inc.","url":"/issuer/0001271214","role":"Director","n_filings":1,"first_seen":"2016-05-17","last_seen":"2016-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001457543","name":"CAREFUSION Corp","url":"/issuer/0001457543","role":"Director, Officer (Chairman and CEO)","n_filings":3,"first_seen":"2013-12-02","last_seen":"2014-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000943819","name":"RESMED INC","url":"/issuer/0000943819","role":"Director, Officer (Chief Executive Officer)","n_filings":43,"first_seen":"2004-11-12","last_seen":"2011-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001308428","retrieved_at":"2026-08-24T05:50:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}